A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
City of Hope Medical Center
Incyte Corporation
Constellation Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Vor Biopharma
Thomas Jefferson University
M.D. Anderson Cancer Center
Ono Pharmaceutical Co. Ltd
Cyclacel Pharmaceuticals, Inc.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Chongqing Precision Biotech Co., Ltd
University of Nebraska
Canadian Cancer Trials Group
Memorial Sloan Kettering Cancer Center
Bellicum Pharmaceuticals
Takeda
Incyte Corporation
M.D. Anderson Cancer Center
Maxinovel Pty., Ltd.
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mirror Biologics, Inc.
Alliance for Clinical Trials in Oncology
Regimmune Corporation
M.D. Anderson Cancer Center
Incyte Corporation
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
Viron Therapeutics Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Il-Yang Pharm. Co., Ltd.
National Institutes of Health Clinical Center (CC)
Stanford University
Milton S. Hershey Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Prism Pharma Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center